I am humbled by the trust my patients place in me and I am always inspired by their courage and resilience while developing a personalized treatment plan, providing the latest in evidence based therapies. After spending time in both academic and private practice settings , I value the importance of integrating latest advancements with the personalized touch that comes from truly knowing and understanding my patients. Working collaboratively with multidisciplinary teams I strive to balance the art of care , ensuring every decision is informed, individualized and guided by the best interests of the patient. I remain deeply grateful for the mentors , colleagues and patients who have shaped my path. My goal is to continue serving as an advocate and partner in care, helping my patients navigate their treatment with dignity and hope while contributing meaningfully to advancements in the field of Oncology.
Clinical Interests
Breast Cancer, Gynecologic Oncology, Hematology
Medical School
University of Medicine and Dentistry of NJ, Stratford, NJ
Residency
Cleveland Clinic Foundation, Cleveland, OH
Fellowship
Cleveland Clinic Foundation, Cleveland, OH
Board Certification
Hematology and Medical Oncology
Publications
Title:
George R, Lichtin A. An elderly man with right hand numbness and polycythemia. Cleveland Clinic Journal of Medicine. 2000;67:250-256
Title:
Finke J, Rayman P, George R, Tannenbaum C, Kolenko V, Uzzo R, Novick A, Bukowski R. Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: Role of nuclear factor kappa B suppression. Clinical Cancer Research.2001; 7:940s
Title:
George R, Lytle B,Lichtin A. Severe valvular and aortic arch calcification in a patient with Gaucher’s variant homozygous for the D409H mutation. Clinical Genetics.2001; 59(5):360-363
Title:
George R, Hoeltge G, Tauson L, Lichtin A. Clinical characteristics of patients with Trisomy 8. Blood 1996;88(suppl):155b
Title:
George R, Dannley R, Goormastic M, Bolwell B, Overmoyer BA. Effect of radiation therapy post high dose chemotherapy/autologous stem cell transplant in women with breast cancer involving lymph nodes. Proc. Am Soc. Clin Oncol 1999; 18:94a
Title:
Hussein M, George R, Saluan MA, Mclain D. Skeletal trauma preceding the development of plasma cell dyscrasia. VII International Multiple Myeloma Workshop,1999;p125
Title:
George R , Boparai N, Bolwell B, Kalaycio M. Allogeneic transplantation with busulfan(BU)/Cytoxan(CY) versus BUCY/VP-16 for acute myelogenous leukemia. Blood 1999;94:383b
Title:
Srkalovic G, George R, Sen K, Thamilarasan M, Klein A, Lichtin A. Doppler echocardiographic assessment of diastolic cardiac function in patients with transfusional iron overload. Blood 1999; 94:21b
Title:
George R, Lytle B, Lichtin A. Severe valvular and aortic arch calcification in a patient with Gaucher’s variant homozygous for D409H mutation. Experimental Hematology 2000; 28:157
Title:
George R, Rayman P, Bukowski R, Finke J. Role of gangliosides in the suppression of nuclear factor kappa B in renal cell carcinoma. National Medical Oncology Fellows Forum.2001
Title:
George R, VanPoznak C, Smith K, Panageas K, Smith M, Norton L, Hudis C. Cardiac Safety Results of Dose- Dense Doxorubicin and Cyclophosphamide followed by Paclitaxel with Transtuzumab in HER2/Neu Overexpressed/ Amplified Breast Cancer. SABCS 2005
Title:
George R, VanPoznak C, Pangeas K, Smith M, Norton L, Hudis C. Polonged dose-dense epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer is feasible. SABCS 2005
Insurance
Accepted Health Plan information is only as accurate as the most current
information submitted. Prior to your appointment, it is advisable to verify
with a physician office that they are still a participating provider.
